Literature DB >> 24357220

Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy.

Genève M Allison1, Eavan G Muldoon, David M Kent, Jessica K Paulus, Robin Ruthazer, Aretha Ren, David R Snydman.   

Abstract

BACKGROUND: Factors associated with readmission for patients prescribed outpatient parenteral antibiotic therapy (OPAT) at hospital discharge have not been definitively identified. The study aim was to develop a model of 30-day readmissions for OPAT patients.
METHODS: A database comprising 782 OPAT patients treated between 2009 and 2011 at a single academic center was created. Variables collected included patient demographics, comorbidities, infections, and antibiotic classes. Final model discrimination was assessed using the c-statistic, and calibration was examined graphically.
RESULTS: Mean patient age was 58 years (range, 18-95 years), 43% were women, and the most common diagnoses were bacteremia (24%), osteomyelitis (20%), and pyelonephritis (13%). The unplanned 30-day readmission rate was 26%. The leading indications for readmission were non-infection related (30%), worsening infection (29%), and new infection (19%). The final regression model consisted of age (odds ratio [OR], 1.09 per decade; 95% confidence interval [CI], 0.99-1.21), aminoglycoside use (OR, 2.33; 95% CI, 1.17-4.57), resistant organisms (OR, 1.57; 95% CI, 1.03-2.36), and number of prior hospital discharges without intravenous antibiotics in the past 12 months (OR, 1.20 per prior admission; 95% CI, 1.09-1.32). The c-statistic was 0.61 and the highest-risk quintile of patients had almost a 3-fold higher rate of readmission compared to the lowest.
CONCLUSIONS: Patients prescribed OPAT are at risk for readmission. A subgroup of patients at especially high risk can be identified using easily obtainable clinical characteristics at the time of hospital discharge. More intensive interventions to prevent OPAT readmissions should be targeted and tested with those at highest risk.

Entities:  

Keywords:  OPAT; aminoglycoside; drug-resistant organisms; predictive model; readmission

Mesh:

Substances:

Year:  2013        PMID: 24357220      PMCID: PMC3935501          DOI: 10.1093/cid/cit920

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

1.  Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.

Authors:  E W Steyerberg; F E Harrell; G J Borsboom; M J Eijkemans; Y Vergouwe; J D Habbema
Journal:  J Clin Epidemiol       Date:  2001-08       Impact factor: 6.437

2.  Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines.

Authors:  Alan D Tice; Susan J Rehm; Joseph R Dalovisio; John S Bradley; Lawrence P Martinelli; Donald R Graham; R Brooks Gainer; Mark J Kunkel; Robert W Yancey; David N Williams
Journal:  Clin Infect Dis       Date:  2004-05-26       Impact factor: 9.079

3.  ROCR: visualizing classifier performance in R.

Authors:  Tobias Sing; Oliver Sander; Niko Beerenwinkel; Thomas Lengauer
Journal:  Bioinformatics       Date:  2005-08-11       Impact factor: 6.937

4.  Ambulatory antimicrobial use: the value of an outcomes registry.

Authors:  Dilip Nathwani; Alan Tice
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

Review 5.  Quality assurance and outcomes in outpatient parenteral antibiotic therapy.

Authors:  M J Kunkel
Journal:  Infect Dis Clin North Am       Date:  1998-12       Impact factor: 5.982

Review 6.  A comparison of goodness-of-fit tests for the logistic regression model.

Authors:  D W Hosmer; T Hosmer; S Le Cessie; S Lemeshow
Journal:  Stat Med       Date:  1997-05-15       Impact factor: 2.373

7.  Predicting hospital readmissions in the Medicare population.

Authors:  G F Anderson; E P Steinberg
Journal:  Inquiry       Date:  1985       Impact factor: 1.730

8.  Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost.

Authors:  L Bernard; B Pron; A Lotthé; V Gleizes; F Signoret; P Denormandie; J L Gaillard; C Perronne
Journal:  J Clin Pharm Ther       Date:  2001-12       Impact factor: 2.512

9.  Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Authors:  Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

10.  Screening elders for risk of hospital admission.

Authors:  C Boult; B Dowd; D McCaffrey; L Boult; R Hernandez; H Krulewitch
Journal:  J Am Geriatr Soc       Date:  1993-08       Impact factor: 5.562

View more
  37 in total

1.  Does electronic medication reconciliation at hospital discharge decrease prescription medication errors?

Authors:  Geneve M Allison; Bernard Weigel; Christina Holcroft
Journal:  Int J Health Care Qual Assur       Date:  2015

2.  Health-related quality of life and its association with outcomes of outpatient parenteral antibiotic therapy.

Authors:  Liang En Wee; Mangaikarasi Sundarajoo; Way-Fang Quah; Ahmad Farhati; Jie-Ying Huang; Ying-Ying Chua
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-23       Impact factor: 3.267

3.  Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infections.

Authors:  A Mujal; J Sola; M Hernandez; M-A Villarino; M-L Machado; M Baylina; J Tajan; J Oristrell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-06       Impact factor: 3.267

4.  Patient satisfaction in an outpatient parenteral antimicrobial therapy (OPAT) unit practising predominantly self-administration of antibiotics with elastomeric pumps.

Authors:  L Saillen; L Arensdorff; E Moulin; R Voumard; C Cochet; N Boillat-Blanco; C Gardiol; S de Vallière
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-11       Impact factor: 3.267

5.  Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches.

Authors:  Boeun Lee; Idy Tam; Bernard Weigel; Janis L Breeze; Jessica K Paulus; Jason Nelson; Genève M Allison
Journal:  J Antimicrob Chemother       Date:  2015-05-29       Impact factor: 5.790

6.  Environmental Exposures and the Risk of Central Venous Catheter Complications and Readmissions in Home Infusion Therapy Patients.

Authors:  Sara C Keller; Deborah Williams; Mitra Gavgani; David Hirsch; John Adamovich; Dawn Hohl; Amanda Krosche; Sara Cosgrove; Trish M Perl
Journal:  Infect Control Hosp Epidemiol       Date:  2016-10-04       Impact factor: 3.254

7.  Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity.

Authors:  C Gardiol; R Voumard; C Cochet; S de Vallière
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-17       Impact factor: 3.267

8.  Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy.

Authors:  Sara C Keller; Deborah Williams; Mitra Gavgani; David Hirsch; John Adamovich; Dawn Hohl; Ayse P Gurses; Sara E Cosgrove
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

9.  Utilizing a Modified Care Coordination Measurement Tool to Capture Value for a Pediatric Outpatient Parenteral and Prolonged Oral Antibiotic Therapy Program.

Authors:  Louise E Vaz; Cindi L Farnstrom; Kimberly K Felder; Judith Guzman-Cottrill; Hannah Rosenberg; Richard C Antonelli
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-15       Impact factor: 3.164

10.  Readmissions With Multidrug-Resistant Infection in Patients With Prior Multidrug Resistant Infection.

Authors:  Jason P Burnham; Jennie H Kwon; Margaret A Olsen; Hilary M Babcock; Marin H Kollef
Journal:  Infect Control Hosp Epidemiol       Date:  2017-12-17       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.